Generation of tumor-specific cytotoxic T-lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T-cell transfer

New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?

(2013) V Boncheva et al.   CANCER GENE THERAPY

Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy

(2013) S. Turcotte et al.   CLINICAL CANCER RESEARCH

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

(2013) Jérôme Galon et al.   JOURNAL OF PATHOLOGY

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

(2013) Cor HJ Lamers et al.   MOLECULAR THERAPY

Melanoma as a model tumour for immuno-oncology

(2012) M. Maio   ANNALS OF ONCOLOGY

A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects

(2012) Harold Tjalsma et al.   NATURE REVIEWS MICROBIOLOGY

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results

(2011) S. Secondino et al.   ANNALS OF ONCOLOGY

Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor

(2011) Daniela Montagna et al.   CYTOTHERAPY

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

(2011) Paul F. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

(2011) Steven A. Rosenberg   Nature Reviews Clinical Oncology

Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy

(2011) Ji Hee Lee et al.   Immune Network

Focus on Adoptive T Cell Transfer Trials in Melanoma

(2010) Liat Hershkovitz et al.   Clinical & Developmental Immunology

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

(2010) M. E. Dudley et al.   CLINICAL CANCER RESEARCH

Tumor-reactive CD4+CD8αβ+ CD103+ αβT cells: A prevalent tumor-reactive T-cell subset in metastatic colorectal cancers

(2010) Guillaume Sarrabayrouse et al.   INTERNATIONAL JOURNAL OF CANCER

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

(2010) Richard A Morgan et al.   MOLECULAR THERAPY

T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

(2010) Maria R Parkhurst et al.   MOLECULAR THERAPY

The methodological approach for the generation of humandendritic cells from monocytes affects the maturation state of the resultant dendritic cells

(2009) Ilaria Mucci et al.   BIOLOGICALS

Adoptive cell therapy for the treatment of patients with metastatic melanoma

(2009) Steven A Rosenberg et al.   CURRENT OPINION IN IMMUNOLOGY

Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo

(2009) Yu-gang Wu et al.   MEDICAL ONCOLOGY

The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy

(2008) Yoon Jeong Heo et al.   CRYOBIOLOGY

Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation

(2008) D. Montagna et al.   International Journal of Immunogenetics

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

(2008) Mark E. Dudley et al.   JOURNAL OF CLINICAL ONCOLOGY